Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
American Journal of Cancer Research|June 14, 2016
Therapeutic evaluation of monoclonal antibody-maytansinoid conjugate as a model of RON-targeted drug delivery for pancreatic cancer treatmentHang-Ping Yao, Liang Feng, Jian-Wei Zhou, et al.Molecular Cancer|May 31, 2011
Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating proteinQi Ma, Sunny Guin, Snehal S Padhye, et al.Addictive Behaviors|July 6, 2013
The effectiveness comparison of Jitai tablets versus methadone in community-based drug treatment: a 1-year follow-up studyShen-Qiang Hao, Min Zhao, Rui-Wen Zhang, et al.Current Cancer Drug Targets|April 20, 2013
Oncogenic variant RON160 expression in breast cancer and its potential as a therapeutic target by small molecule tyrosine kinase inhibitorHang-Ping Yao, Chun-Mei Zhuang, Yong-Qing Zhou, et al.Molecular Cancer|July 14, 2011
The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cellsHang-Ping Yao, Yong-Qing Zhou, Qi Ma, et al.International Journal of Environmental Research and Public Health|February 2, 2016
Factors Associated with Relapse among Heroin Addicts: Evidence from a Two-Year Community-Based Follow-Up Study in ChinaChao Rong, Hai-Feng Jiang, Rui-Wen Zhang, et al.Ecotoxicology and Environmental Safety|April 24, 2013
Hair analysis, a reliable and non-invasive method to evaluate the contamination by clenbuterolJing-Ying Jia, Lu-Nan Zhang, You-Li Lu, et al.Pageof 1